Signaling scaffolds in immune cells.
Of the past several years progress in understanding TCR signal transduction has led to the discovery of new kinases, adapter molecules and multiple signaling pathways. The study of molecules such as LAT, SLP-76, FYB, SKAP-55 and VAV have revealed multiple mechanisms with which to control the activation of downstream signaling pathways through RAS, PLC gamma-1 and ERK/MAPK. Signaling through SLP-76 can play a role in TCR-induced cytoskeleton changes through activation of effector molecules in the RAC/RHO-family of GTPases. In addition, SLP-76 through its association with FYB/FYN-T appears to play a role in IL-2 gene transcription following TCR activation. Finally, these newly identified adaptor molecules, such as LAT, may be crucial in T-cell activation by enhancing the recruitment of critical kinases to glycolipid-enriched microdomains of the activated T-cell receptor complex.
Kennedy
J S
JS
Department of Cancer Immunology and AIDS, Harvard Medical School, Boston, USA.
Raab
M
M
Rudd
C E
CE
D000818:Animals; D000939:Epitopes; D008213:Lymphocyte Activation / Q000502:physiology; D010770:Phosphotransferases / Q000502:physiology*; D011948:Receptors, Antigen, T-Cell / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology*; D013601:T-Lymphocytes / Q000502:physiology*
D000939:Epitopes; D011948:Receptors, Antigen, T-Cell; D010770:Phosphotransferases